Status:

COMPLETED

Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients

Lead Sponsor:

Texas A&M University

Collaborating Sponsors:

University of Arkansas

Conditions:

Non-small Cell Lung Cancer

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

Weight loss commonly occurs in lung cancer patients, negatively influencing their quality of life, treatment response and survival. Gains in lean body mass are difficult to achieve in cancer unless sp...

Detailed Description

In this study, we will test the following hypothesis: A high-leucine essential amino acid mixture stimulates whole body protein synthesis (and in this way protein anabolism) to a larger extent than a ...

Eligibility Criteria

Inclusion

  • Recently diagnosed with Stage III (unresectable) or Stage IV lung cancer (only for the NSCLC group)
  • Ability to sign informed consent
  • Age 40 years and older

Exclusion

  • Previous anti-cancer therapy (e.g. radiotherapy, chemotherapy) or surgery less than 4 weeks prior to the experiment.
  • Presence of fever within the last 3 days
  • Established diagnosis of Diabetes Mellitus
  • BMI \> 35 kg/m2
  • Untreated metabolic diseases including hepatic or renal disorder
  • Presence of acute illness or metabolically unstable chronic illness
  • Use of long-term oral corticosteroids or short course of oral corticosteroids in the preceding month before enrollment
  • Diagnosis of moderate to severe chronic airflow limitation, defined as measured forced expiratory volume in one second (FEV1) ≤ 70% of referen¬ce FEV1 (only for the healthy control group)
  • Use of supplements enriched with amino acids
  • Any other condition according to the PI or study physicians would interfere with proper conduct of the study / safety of the patient
  • Failure to give informed consent

Key Trial Info

Start Date :

July 13 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 22 2012

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT01172314

Start Date

July 13 2010

End Date

February 22 2012

Last Update

September 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205